Food Is Medicine for Patients With Heart Failure
1 other identifier
interventional
60
1 country
2
Brief Summary
This study will look at the effects of providing medically tailored meals (MTMs) to people with heart disease for twelve weeks. The primary outcome of the study is the quality of the diet being consumed in week 12 of the study, as determined by the "Healthy Eating Index."
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started Oct 2024
Shorter than P25 for not_applicable heart-failure
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 24, 2024
CompletedFirst Posted
Study publicly available on registry
August 6, 2024
CompletedStudy Start
First participant enrolled
October 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 28, 2025
CompletedJanuary 26, 2026
January 1, 2026
9 months
July 24, 2024
January 22, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in diet quality at Week 12, as determined by the Healthy Eating Index (HEI)
HEI will be used to determine diet quality based on dietary recall data collected via Nutrition Data System for Research (NDSR) software. HEI scores range from 0 to 100. An ideal overall HEI score of 100 reflects that the set of foods aligns with key dietary recommendations and dietary patterns published in the Dietary Guidelines for Americans.
Baseline and Week 12
Secondary Outcomes (9)
Participant satisfaction with delivery of medically tailored meals for individuals with heart failure
Week 4 and Week 12
Dietary adherence to meal assignment using daily food diaries and 24-hour dietary recalls
Baseline and Weeks 4, 6, 8, and 12
Change in reported access to healthy foods as assessed by the Food Consumption Score (FCS)
Baseline, Week 12, and Week 24
Change in reported food security as assessed by the Food Insecurity Experience Scale (FIES)
Baseline, Week 12, Week 24
Change in reported food security as assessed by the Short Form of the U.S. Adult Food Security Survey Module
Baseline, Week 12, Week 24
- +4 more secondary outcomes
Study Arms (2)
15 Medically Tailored Meals (MTM) + snacks
EXPERIMENTALParticipants will receive 15 medically tailored meals (MTM) per week, plus snacks, for 12 weeks.
14 Medically Tailored Meals (MTM)
EXPERIMENTALParticipants will receive 14 medically tailored meals (MTM) per week for 12 weeks.
Interventions
14 heart-healthy medically tailored meals delivered to participants each week. Meals include lunch and dinner to consume Monday-Sunday.
15 heart-healthy medically tailored meals delivered to participants each week. Meals include breakfast, lunch, dinner, and snack to consume Monday-Friday.
Eligibility Criteria
You may qualify if:
- Willingness to comply with all study procedures and availability for the duration of the study
- Living in San Diego or the Bay Area of California
- Reported congestive heart failure (CHF) diagnosis
- Current diet can be improved
- Willing to eat all meals provided by the study
You may not qualify if:
- Diagnosed with end-stage heart failure
- Diagnosed with diabetes (type 1 or uncontrolled type 2)
- Currently taking insulin and/or meglitinides medications
- Currently taking Glucagon-Like Peptide-1 (GLP-1) Agonists medications and not stable on a maximum maintenance dose for a minimum of 1 month
- Hemoglobin A1c (HbA1c) results \>8 %
- Life expectancy of \<1 year
- Pregnancy or lactation
- Known severe allergic reactions and/or food intolerances that would interfere with the ability to eat study-provided meals, including foods that are prepared in a facility that works with the allergen
- Current smoker or tobacco use within the past year
- Planning to leave San Diego or the Bay Area during the course of the study
- Unable to communicate reasonably well either orally or through written material in English
- Those who, in the opinion of the investigators, cannot reliably complete the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, San Diegolead
- Stanford Universitycollaborator
Study Sites (2)
University of California San Diego
La Jolla, California, 92093, United States
Stanford University
Stanford, California, 94305, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cheryl Anderson, PhD, MPH, MS
UC San Diego
- PRINCIPAL INVESTIGATOR
Christopher Gardner, PhD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- By the nature of the dietary intervention, it is impossible to blind participants to study arm assignment. However, research staff collecting outcome data, apart from dietary adherence data, will remain blinded to participants' assigned study arm throughout data collection. Additionally, the statistician(s) analyzing data for efficacy of the intervention will use a dataset with study arm masked in order to remain blinded to the assigned intervention for the final analysis.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Dean
Study Record Dates
First Submitted
July 24, 2024
First Posted
August 6, 2024
Study Start
October 17, 2024
Primary Completion
July 28, 2025
Study Completion
July 28, 2025
Last Updated
January 26, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share